Efficient electrostatic solvation model for protein-fragment docking.
about
Computational methods in drug discoveryDiscovery of a Non-Peptidic Inhibitor of West Nile Virus NS3 Protease by High-Throughput DockingIn silicoidentification and crystal structure validation of caspase-3 inhibitors without a P1 aspartic acid moietyExperimental and computational active site mapping as a starting point to fragment-based lead discoveryDiscovery of plasmepsin inhibitors by fragment-based docking and consensus scoringA directed essential dynamics simulation of peptide folding.Fragment-based docking: development of the CHARMMing Web user interface as a platform for computer-aided drug design.Inhibiting the p53-MDM2 interaction: an important target for cancer therapy.Site Identification by Ligand Competitive Saturation (SILCS) simulations for fragment-based drug designDrugs targeting protein-protein interactions.Docking, virtual high throughput screening and in silico fragment-based drug designInhibitors of MDM2 and MDMX: a structural perspective.Fragment informatics and computational fragment-based drug design: an overview and update.Structure-guided fragment-based in silico drug design of dengue protease inhibitors.Progress toward virtual screening for drug side effects.Comparing pairwise-additive and many-body generalized Born models for acid/base calculations and protein design.Reducing the Flexibility of Type II Dehydroquinase for Inhibition: A Fragment-Based Approach and Molecular Dynamics Study.Fragment-Based flexible ligand docking by evolutionary optimization.Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple).
P2860
Q26997089-8616DAAC-3FB4-4647-B31F-0454FFA3D9E9Q27487538-98DA79BA-0EC3-4428-8510-28E9F23AD426Q27671584-799A3B48-CB2B-4A36-960C-DEE9A4DE9A82Q27676521-20AAB9B4-724D-411A-8829-1DB98640E60DQ28246329-93C2BB57-4486-4875-8C71-D90556BB2721Q34190165-953CFD28-3EB9-49BF-9352-F5EE2FEC7AC7Q34222933-4018EDBD-BE42-4BA0-AC13-C0F2A4593070Q35058579-EAC3558A-7CF2-47CA-A034-A939AEEEC721Q35566613-5B2707E6-DA63-4E4F-B801-5AE035FFA545Q36558129-EBCDA655-F890-48AE-82BB-7E267A799A93Q37296002-26A53CAD-0F78-4341-8A0F-88C519C5CAD0Q37855826-D37CB569-5377-4519-9A19-24F5089D6F8DQ37995087-8120B05B-7BD5-43E4-B684-2ADE9084830FQ40333119-6823622F-D8EC-43CE-8DAE-277CDE0692CBQ44125156-A9EA1BE7-3CDB-4135-9D38-8060E6DE0823Q48021670-E7228514-B17F-410D-9239-52FA5E223B71Q48056331-84CE18BD-7E7A-48A4-80E4-E049E2E02F24Q52052521-724890FB-1432-40C2-9EA3-AABF5496AC7BQ52659146-4E243115-E35C-49BC-8E25-14F3A310FC41
P2860
Efficient electrostatic solvation model for protein-fragment docking.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Efficient electrostatic solvation model for protein-fragment docking.
@ast
Efficient electrostatic solvation model for protein-fragment docking.
@en
type
label
Efficient electrostatic solvation model for protein-fragment docking.
@ast
Efficient electrostatic solvation model for protein-fragment docking.
@en
prefLabel
Efficient electrostatic solvation model for protein-fragment docking.
@ast
Efficient electrostatic solvation model for protein-fragment docking.
@en
P2093
P2860
P1433
P1476
Efficient electrostatic solvation model for protein-fragment docking.
@en
P2093
P2860
P304
P356
10.1002/1097-0134(20010201)42:2<256::AID-PROT130>3.0.CO;2-4
P407
P577
2001-02-01T00:00:00Z